Deutsche Bank’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CKPT
JSMC
Deutsche Bank's CKPT Position: Q1 2022 in Review
Deutsche Bank sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 80 shares — an estimated $2K sold.
Deutsche Bank first reported a position in CKPT in Q3 2018 and held it in 12 quarters. The position peaked at $1.4M in Q1 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.
- Deutsche Bank reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
- Deutsche Bank sold 80 Checkpoint Therapeutics shares in Q1 2022, an estimated $2K.
- Deutsche Bank first reported a position in Checkpoint Therapeutics in Q3 2018 and held it in 12 quarters.
- Deutsche Bank's Checkpoint Therapeutics position peaked at $1.4M in Q1 2021.
- 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.
Based on Deutsche Bank's 13F filing for Q1 2022, filed 13 May 2022.